Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Oral treatment for visceral leishmaniasis (kala-azar). | Powerful IV antifungal for life-threatening infections. |
| Body system | Antiparasitics | Antifungals |
| Drug class | Other antiparasitic medicines | Polyenes |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Visceral leishmaniasis (kala-azar), Cutaneous and mucocutaneous leishmaniasis | Cryptococcal meningitis, Mucormycosis, Invasive aspergillosis and candidiasis, Visceral leishmaniasis (kala-azar) |
| How it works | Kills Leishmania parasites in the spleen, liver and bone marrow. | Binds to fungal membranes and makes them leak. |
| Starts working | Weeks | — |
| Half-life | About 7–31 days | About 1–2 weeks terminal |
| Typical adult dose | 50 mg capsule twice or three times a day for 28 days, based on body weight. | Liposomal: typically 3–5 mg/kg a day by infusion; single high-dose regimens exist for some infections. |
| Forms | Capsule | IV infusion (conventional and liposomal) |
| Common side effects | Vomiting, Diarrhoea, Reduced appetite, Raised liver enzymes | Fever and shivering during infusion, Low potassium and magnesium, Nausea |
| Serious side effects | Birth defects, Kidney injury, Severe skin reactions | Kidney injury, Severe electrolyte loss, Infusion reactions |
| Don't take if | Pregnancy; Breastfeeding; Sjögren-Larsson syndrome | — |
| Alcohol | Best to limit. Alcohol adds to vomiting and liver stress. | — |
| Pregnancy | Usually avoidedContraindicated: causes birth defects. | Use with cautionUsed for serious infection; preferred antifungal in pregnancy when systemic treatment is needed. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | — | 1958 |
| Brand names | India: Miltefosine (generic), ImpavidoUnited States: ImpavidoUnited Kingdom: Impavido | United States: AmBisome, AbelcetUnited Kingdom: AmBisomeIndia: Amphonex, Fungisome |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | L01XX09 | J02AA01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker